Next-Gen Aquaculture in India: Harnessing RAS and Bio-floc Technology in Blue Economy (See 'Corp Brief') Fighting Air Pollution is continuous Programme: EFCC Secretary (See 'Corp Brief') From Struggles to Success: KVIC is Inspiring Entrepreneurial Journeys (See 'Corp Brief') NI Act is not primarily punitive rather is compensatory in nature, with focus on recovery of amount in question: HC (See 'Legal Desk') India should target 10 Million Medical Value Tourists Annually: Goyal (See 'Corp Brief') CIL's daily Average Production Rises 35% (See 'Corp Brief') e-FAST India launches PACT to support accelerated zero-emission freight deployment in India (See 'Corp Brief') Chouhan reviews action plan for strengthening KVKs through greater State participation (See 'Corp Brief') CPC - leave granted u/s Clause XII of the Letters Patent confers jurisdiction exclusively on High Court & does not bind or preserve the territorial jurisdiction of a subordinate civil court upon transfer: HC (See 'Legal Desk') Minister says early industry participation can make technologies market-ready (See 'Corp Brief') Dynamic Local Level Planning imperative for documenting Local Biodiversity: Yadav (See 'Corp Brief') National Zoological Park Organises Sunday Bird, Butterfly and Dragonfly Walks to Promote Science (See 'Corp Brief') SEBI - Writ court's intervention is required in a private contractual dispute between petitioner & broker where any contractual or statutory remedies available under SEBI Act is not invoked: HC (See 'Legal Desk') 1st Batch of Corporate Mitra Course Commences with 2879 Learners registered (See 'Corp Brief') SAIL posts strong sales and production growth in August 2026 (See 'Corp Brief') MoS felicitates 'Team India School Children' for Historic Best-Ever Performance (See 'Corp Brief') Coal India Output and Dispatch Set to Accelerate as Monsoon Effect Wanes (See 'Corp Brief') SEBI - Any notice or assessment order is invalid where passed in respect of an entity that has been struck off Register of Companies & has since been dissolved: SEBI (See 'Legal Desk') MoS launches BIO-NIVESH to Catalyse Investment and Scale-Up of Biotechnology Innovations (See 'Corp Brief') Media Registration Open for SEMICON India 2026 (See 'Corp Brief') CPC - Objection regarding pecuniary jurisdiction cannot be entertained at stage of final arguments when no such objection is raised by defendant at earliest opportunity or before settlement of issues: HC (See 'Legal Desk') Nadda inaugurates Centre for Advanced Bladder Diagnostics (See 'Corp Brief') NIELIT and Intel India launch Agentic AI Skilling Programs (See 'Corp Brief') IBC - IRP has contravened statutory mandate of IBC by omitting to maintain formal minutes of meetings & relying instead on informal email communications & where IRP omits to act strictly as per prior instructions of CoC: IBBI (See 'Legal Desk') BRICS Members reaffirm Commitment for Multilateral Cooperation in Intellectual Property (See 'Corp Brief') Digital India BHASHINI and Kathmandu Univ explore Collaboration in Language AI (See 'Corp Brief') IBCA, ADB sign MoU strengthening collaboration in Landscape Conservation (See 'Corp Brief') IPR - For deciding territorial jurisdiction at inception of suit, if plaintiff's pleadings sufficiently allege that defendant has digital presence accessible, suit cannot be summarily thrown out for lack of jurisdiction: HC (See 'Legal Desk') EPFO seeks applications from potential beneficiaries (See 'Corp Brief') CCI okays acquisition of up to 100% equity of Apollo Fertility & Apollo Specialty by Kids Clinic India (See 'Corp Brief') IBC - Definition of 'associate' u/s 79(2)(g) cannot be expanded beyond its statutory text, and procedural irregularities such as absence of forensic audit do not warrant rejection if no actual prejudice is demonstrated: NCLT (See 'Legal Desk') Wow! 7.8% growth but it also does not reveal many things! (See CORP EINSICHT)

NPPA monitors prices of scheduled & non-scheduled medicines

Published: Jul 30, 2024

By TIOLCorplaws News Service

NEW DELHI, JULY 30, 2024: AS per the provisions of Drugs (Prices Control) Order, 2013 (DPCO, 2013), formulations listed in Schedule-I of the DPCO are defined as scheduled formulation under section 2(1)(zb) of DPCO, 2013. Formulations not included in Schedule-I are defined under Para 2(1)(v) of DPCO, 2013 as non-scheduled formulation. Thus, both schedule and non-schedule drugs are covered under DPCO, 2013. 

As per the extant provisions of DPCO, 2013, the ceiling prices of scheduled medicines are revised annually on the basis of Wholesale Price Index (WPI) (all commodities) for preceding calendar year by National Pharmaceutical Pricing Authority (NPPA), on or before 1st April of every year and is notified by the Government on the 1st day of April every year. The details of price fixed by NPPA are available at NPPA's website i.e. nppaindia.nic.in.  In case of non-scheduled formulation (branded or generic), as per para 20 of DPCO, 2013, no manufacturers can increase Maximum Retail Price (MRP) by more than 10% of MRP during preceding 12 months.  The maximum permissible increase in prices, as per the provisions of DPCO, 2013 for scheduled and non-scheduled drugs may or may not be availed by their respective manufacturers based on commercial considerations and market dynamics.

Under the Drugs and Cosmetics Act, 1945 and Rules thereunder, manufacturers of drugs are required to comply with conditions of manufacturing licence and the requirements of Good Manufacturing Practices (GMP).  As per the Drugs Rules, 1945, the manufacturing, testing, labeling, packaging, storage and distribution are required to be carried out in compliance with the conditions of license including the Good manufacturing practices (GMP) prescribed under the Schedule M of the Drugs Rules, 1945. In case of violation, the Licensing Authority is empowered to take action as per the said Act and Rules.

NPPA monitors the prices of scheduled as well as non-scheduled medicines under DPCO, 2013.  Action is taken against companies, found selling formulations at prices higher than the permissible price, and the overcharged amount is recovered from the company as per the relevant provisions of the DPCO, 2013. During the financial year 2023-24, Rs. 72.73 crore was recovered from the defaulting companies.

This information was given by the Union Minister of State for Chemicals and Fertilizers Anupriya Patel in Rajya Sabha in reply to a question today.

TIOL CORP SEARCH

TIOL GROUP WEBSITES